"Research Design" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
Descriptor ID |
D012107
|
MeSH Number(s) |
E05.581.500 H01.770.644.728
|
Concept/Terms |
Research Design- Research Design
- Design, Research
- Designs, Research
- Research Designs
Research Strategy- Research Strategy
- Research Strategies
- Strategies, Research
- Strategy, Research
Error Sources- Error Sources
- Error Source
- Source, Error
- Sources, Error
Scoring Methods- Scoring Methods
- Method, Scoring
- Methods, Scoring
- Scoring Method
Matched Groups- Matched Groups
- Group, Matched
- Groups, Matched
- Matched Group
Research Techniques- Research Techniques
- Research Technique
- Technique, Research
- Techniques, Research
- Research Technics
- Research Technic
- Technic, Research
- Technics, Research
Research Proposal- Research Proposal
- Proposal, Research
- Proposals, Research
- Research Proposals
Data Adjustment- Data Adjustment
- Adjustment, Data
- Adjustments, Data
- Data Adjustments
Problem Formulation- Problem Formulation
- Formulation, Problem
- Formulations, Problem
- Problem Formulations
Experimental Design- Experimental Design
- Experimental Designs
- Design, Experimental
- Designs, Experimental
|
Below are MeSH descriptors whose meaning is more general than "Research Design".
Below are MeSH descriptors whose meaning is more specific than "Research Design".
This graph shows the total number of publications written about "Research Design" by people in this website by year, and whether "Research Design" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 4 | 3 | 7 |
1997 | 1 | 8 | 9 |
1998 | 0 | 3 | 3 |
1999 | 0 | 5 | 5 |
2000 | 0 | 5 | 5 |
2001 | 2 | 8 | 10 |
2002 | 6 | 4 | 10 |
2003 | 2 | 10 | 12 |
2004 | 5 | 10 | 15 |
2005 | 4 | 7 | 11 |
2006 | 4 | 13 | 17 |
2007 | 5 | 19 | 24 |
2008 | 4 | 14 | 18 |
2009 | 3 | 14 | 17 |
2010 | 4 | 8 | 12 |
2011 | 8 | 17 | 25 |
2012 | 19 | 14 | 33 |
2013 | 9 | 15 | 24 |
2014 | 10 | 7 | 17 |
2015 | 12 | 12 | 24 |
2016 | 6 | 9 | 15 |
2017 | 9 | 15 | 24 |
2018 | 16 | 12 | 28 |
2019 | 14 | 16 | 30 |
2020 | 11 | 11 | 22 |
2021 | 8 | 16 | 24 |
2022 | 5 | 8 | 13 |
2023 | 6 | 11 | 17 |
2024 | 5 | 8 | 13 |
2025 | 7 | 1 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Research Design" by people in Profiles.
-
Protocol for a global menopause priority setting partnership. BMJ Open. 2025 Jun 04; 15(6):e096401.
-
Study design and the sampling of deleterious rare variants in biobank-scale datasets. Proc Natl Acad Sci U S A. 2025 Jun 10; 122(23):e2425196122.
-
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer. Lancet Oncol. 2025 May; 26(5):e253-e263.
-
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials. JAMA Netw Open. 2025 May 01; 8(5):e2512763.
-
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design. Lancet Gastroenterol Hepatol. 2025 Jun; 10(6):593-604.
-
On the use of external controls in clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 01; 2025(68):30-34.
-
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 01; 2025(68):22-29.
-
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub. Circ Cardiovasc Qual Outcomes. 2025 Mar; 18(3):e000128.
-
Irregular assessment times in pragmatic randomized clinical trials. Trials. 2024 Dec 20; 25(1):841.
-
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges. Lancet Respir Med. 2025 Feb; 13(2):177-188.